Persistent fever due to coronavirus disease 2019 (COVID-19) is a considerable issue for patients and physicians that requires a broad differential diagnosis and evaluation of complications. Coinfections with severe acute respiratory syndrome
COVID-19 and Tuberculosis (TB) are among the major global public health problems and diseases with major socioeconomic impacts. The dynamics of these diseases are spread throughout the world with clinical similarities which makes them difficult to be
Description of three cases of 4-7-year-old male children presenting with a seizure without a prior history of epilepsy, 2-4 weeks after recovering from COVID-19. All three children were admitted to the pediatric department at Laniado Hospital in
The coronavirus disease of 2019 (COVID-19) pandemic created a variety of symptoms from mild to acute in the general population. Additional disease burden was experienced in high-risk populations, such as older adults, people with disabilities or
The SARS-CoV2 Omicron variants have acquired new Spike mutations leading to escape from the most of the currently available monoclonal antibody treatments reducing the options for patients suffering from severe Covid-19. Recently, both in vitro and
In recent years, the world has encountered many epidemic impacts caused by various viruses, COVID-19 has spread and mutated globally since its outbreak in 2019, causing global impact. Nucleic acid detection is an important means for the prevention
Interleukin 6 (IL-6) is a cytokine with dual functions of pro-inflammation and anti-inflammation. It is mainly produced by mononuclear macrophages, Th2 cells, vascular endothelial cells and fibroblasts. IL-6 binds to glycoprotein 130 and one of these
Nirmatrelvir/ritonavir (Paxlovid), an oral antiviral medication targeting SARS-CoV-2, remains an important treatment for COVID-19. Initial studies of nirmatrelvir/ritonavir were performed in SARS-CoV-2 unvaccinated patients without prior confirmed